1. Home
  2. IRD vs FTEK Comparison

IRD vs FTEK Comparison

Compare IRD & FTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRD
  • FTEK
  • Stock Information
  • Founded
  • IRD 2018
  • FTEK 1987
  • Country
  • IRD United States
  • FTEK United States
  • Employees
  • IRD N/A
  • FTEK N/A
  • Industry
  • IRD
  • FTEK Pollution Control Equipment
  • Sector
  • IRD
  • FTEK Industrials
  • Exchange
  • IRD NYSE
  • FTEK Nasdaq
  • Market Cap
  • IRD 36.0M
  • FTEK 31.9M
  • IPO Year
  • IRD N/A
  • FTEK N/A
  • Fundamental
  • Price
  • IRD $1.13
  • FTEK $0.93
  • Analyst Decision
  • IRD Strong Buy
  • FTEK Strong Buy
  • Analyst Count
  • IRD 1
  • FTEK 1
  • Target Price
  • IRD $8.00
  • FTEK $4.00
  • AVG Volume (30 Days)
  • IRD 150.5K
  • FTEK 109.4K
  • Earning Date
  • IRD 02-24-2025
  • FTEK 03-10-2025
  • Dividend Yield
  • IRD N/A
  • FTEK N/A
  • EPS Growth
  • IRD N/A
  • FTEK N/A
  • EPS
  • IRD N/A
  • FTEK N/A
  • Revenue
  • IRD $8,381,000.00
  • FTEK $26,195,000.00
  • Revenue This Year
  • IRD N/A
  • FTEK N/A
  • Revenue Next Year
  • IRD $29.37
  • FTEK $14.71
  • P/E Ratio
  • IRD N/A
  • FTEK N/A
  • Revenue Growth
  • IRD N/A
  • FTEK N/A
  • 52 Week Low
  • IRD $0.81
  • FTEK $0.91
  • 52 Week High
  • IRD $2.71
  • FTEK $1.34
  • Technical
  • Relative Strength Index (RSI)
  • IRD N/A
  • FTEK 34.07
  • Support Level
  • IRD N/A
  • FTEK $0.93
  • Resistance Level
  • IRD N/A
  • FTEK $1.01
  • Average True Range (ATR)
  • IRD 0.00
  • FTEK 0.03
  • MACD
  • IRD 0.00
  • FTEK -0.00
  • Stochastic Oscillator
  • IRD 0.00
  • FTEK 15.00

About IRD OPUS GENETICS INC

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA) and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

About FTEK Fuel Tech Inc.

Fuel Tech Inc is an technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.

Share on Social Networks: